EUVIMEDEUVIMED entdecken
Open Access

DADS Regulates EMT and Chemotherapy Resistance by Inhibiting RORα/β-Catenin Signaling through PKCα-Dependent Phosphorylation in Gastric Cancer

Yizhen Zhang, Juan Li, Huanqing Liu, Hong Xia, Jian Su, Fang Liu, Bo Su, Qi Su

Oncology Research · 2025

DOI: 10.32604/or.2025.068689 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2025. Verfasst von Yizhen Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Province Key Laboratory of Cancer Cellular and Molecular Pathology, Cancer Research Institute, University of South China, Hengyang, 421001, Chi…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Epithelial-Mesenchymal Transition, Drug Resistance, Neoplasm, Protein Kinase C-alpha. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsEpithelial-Mesenchymal TransitionDrug Resistance, NeoplasmProtein Kinase C-alphabeta CateninNuclear Receptor Subfamily 1, Group F, Member 1HumansCell Line, TumorPhosphorylationCell ProliferationFluorouracilCell MovementSignal TransductionApoptosisGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

Diallyl disulfidedrug resistanceepithelial-mesenchymal transitiongastric cancer cellsretinoid-related orphan receptor alpha (RORα)/β-catenin signaling

Substanzen

Protein Kinase C-alphabeta CateninNuclear Receptor Subfamily 1, Group F, Member 1FluorouracilRORA protein, humanPRKCA protein, humanCTNNB1 protein, human

Autor:innen und Institutionen

  • Hunan Province Key Laboratory of Cancer Cellular and Molecular Pathology, Cancer Research Institute, University of South China, Hengyang, 421001, China.
  • Department of Pathology, The Affiliated Hospital, Jinggangshan University, Ji'an, 343000, China.
  • Department of Geriatric Medicine, Loudi Central Hospital, Loudi, 417000, China.
  • Department of Oncology, Changsha County People's Hospital, Changsha, 410100, China.
  • Hunan Clinical Research Center for Gastric Cancer Prevention and Treatment, Second Affiliated Hospital, University of South China, Hengyang, 421001, China.
  • Key Laboratory for Pharmacoproteomics of Hunan Provincial University, Institute of Pharmacy and Pharmacology, University of South China, Hengyang, 421001, China.

Zitieren

APA

Zhang, Y., Li, J., Liu, H., Xia, H., Su, J., Liu, F., Su, B., & Su, Q. (2025). DADS Regulates EMT and Chemotherapy Resistance by Inhibiting RORα/β-Catenin Signaling through PKCα-Dependent Phosphorylation in Gastric Cancer. Oncology Research. https://doi.org/10.32604/or.2025.068689

Vancouver

Zhang Y, Li J, Liu H, Xia H, Su J, Liu F, et al. DADS Regulates EMT and Chemotherapy Resistance by Inhibiting RORα/β-Catenin Signaling through PKCα-Dependent Phosphorylation in Gastric Cancer. Oncology Research. 2025. doi:10.32604/or.2025.068689

BibTeX
@article{Zhang2025,
  author = {Zhang, Yizhen and Li, Juan and Liu, Huanqing and Xia, Hong and Su, Jian and Liu, Fang and Su, Bo and Su, Qi},
  title = {DADS Regulates EMT and Chemotherapy Resistance by Inhibiting RORα/β-Catenin Signaling through PKCα-Dependent Phosphorylation in Gastric Cancer},
  journal = {Oncology Research},
  year = {2025},
  doi = {10.32604/or.2025.068689}
}
Kostenlos starten →